Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 20

Outcome	Group	Category	Value	Spread	Units
Walking Speed During Timed 25-foot Walk	Dalfampridine	Change from baseline to 2 weeks	0.3342	Full Range 0.0975 to 0.5709	feet/second
Walking Speed During Timed 25-foot Walk	Placebo	Change from baseline to 2 weeks	0.4745	Full Range 0.2294 to 0.7195	feet/second
Walking Speed During Timed 25-foot Walk	Dalfampridine	Change from baseline to 4 weeks	0.4593	Full Range 0.2071 to 0.7114	feet/second
Walking Speed During Timed 25-foot Walk	Placebo	Change from baseline to 4 weeks	0.1743	Full Range -0.06251 to 0.4111	feet/second
Walking Speed During Timed 25-foot Walk	Dalfampridine	Change from baseline to 6 weeks	0.5445	Full Range 0.1018 to 0.9872	feet/second
Walking Speed During Timed 25-foot Walk	Placebo	Change from baseline to 6 weeks	0.5697	Full Range 0.1596 to 0.9799	feet/second
Walking Speed During Timed 25-foot Walk	Dalfampridine	Change from baseline to 8 weeks	0.3803	Full Range -0.0113 to 0.7719	feet/second
Walking Speed During Timed 25-foot Walk	Placebo	Change from baseline to 8 weeks	0.2101	Full Range -0.1757 to 0.5959	feet/second
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Supine Left Hip Flexor	.6420	95% Confidence Interval -7.3278 to 8.6118	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Supine Left Hip Flexor	-0.05187	95% Confidence Interval -6.3646 to 6.2609	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Supine Right Hip Flexor	2.5774	95% Confidence Interval -2.4644 to 7.6192	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Supine Right Hip Flexor	2.854	95% Confidence Interval -1.31 to 7.018	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Prone Left Hip Flexor	3.286	95% Confidence Interval -6.5985 to 13.1717	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Prone Left Hip Flexor	-1.497	95% Confidence Interval -10.053 to 7.0572	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Prone Right Hip Flexor	3.9752	95% Confidence Interval -6.8518 to 14.8022	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Prone Right Hip Flexor	-4.4162	95% Confidence Interval -13.7929 to 4.9604	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Left Grip	3.1594	95% Confidence Interval -4.844 to 11.1628	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Left Grip	-2.9007	95% Confidence Interval -10.7863 to 4.9849	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Dalfampridine	Right Grip	-1.3602	95% Confidence Interval -6.7146 to 3.9942	Pounds
Upper and Lower Extremity Muscle Strength Measurements	Placebo	Right Grip	2.1665	95% Confidence Interval -3.1048 to 7.4378	Pounds

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02166346/results

API reference For AI assistants